Pentair plc · PNR · FY2025 Q4 · Calendar Q1 2026

Pentair pairs 2026 growth outlook with portfolio and margin initiatives

The supplied analysis supports a constructive but conditional view: management’s raised 2026 outlook, portfolio shift toward higher-margin businesses, product innovation and transformation program provide evidence for growth and margin resilience. The case remains dependent on residential-market recovery, pricing, tariff and FX mitigation, and execution of integration and savings initiatives.

Reported Before market openNYSEIndustrials $8.46B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $1.18 Consensus $1.17
EPS surprise +0.9% Reported versus consensus
Reported revenue $1.02B Consensus $1.01B
Revenue surprise +1.3% Reported versus consensus

Market reaction

prior-close to event-session close
Stock move -10.2% Event window
SPY move -0.8% Same window
Abnormal move -9.3% Stock minus SPY
Volume 4.0× Versus trailing sessions
Subsequent drift +2.3% Up to 20 sessions
PNRSPY benchmark

Ask FN2 about PNR FY2025 Q4

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Relative to the prior-quarter analysis, management’s focus broadened from the HydroStop and 8020 initiatives to a 2026 plan centered on the residential flow/water-solutions combination, new product launches, digital and AI investment, and $70 million of transformation savings. The supplied current analysis also identifies tariff and FX exposure, residential recovery and pool competition as key tests of the outlook.

Guidance delta

Management raised its outlook for fiscal 2026 to 3–4% sales growth and $5.25–$5.40 adjusted EPS, while targeting $70 million of transformation savings.

Key takeaways

  • Pentair reported record full-year 2025 results and strong free cash flow, according to the supplied analysis.
  • Management is combining residential flow and water-solutions activities and emphasizing higher-margin businesses through its 8020 strategy.
  • Product launches, digital and AI investment, and transformation savings are the main operating supports for the 2026 outlook.
  • Tariffs, FX, inflation, residential-market recovery and pool competition remain the principal risks.

Management priorities

  • Execute the 8020 strategy and expand higher-margin businesses.
  • Launch and scale PFAS Everpure, Manitowoc ICE Neo and other high-value products.
  • Capture channel synergies from the residential flow and water-solutions combination.
  • Invest in digital, AI and innovation while maintaining disciplined capital allocation.

Follow PNR with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
PNR EPS earnings history estimate and actual scatter chart 9 reported fiscal quarters and 4 future estimate-only quarters. Q1 '24 estimate $0.90 Q1 '24 actual $0.94, beat Q2 '24 estimate $1.14 Q2 '24 actual $1.22, beat Q3 '24 estimate $1.07 Q3 '24 actual $1.09, beat Q2 '25 estimate $1.34 Q2 '25 actual $1.39, beat Q3 '25 estimate $1.18 Q3 '25 actual $1.24, beat Q4 '25 estimate $1.17 Q4 '25 actual $1.18, match Q1 '26 estimate $1.17 Q1 '26 actual $1.22, beat Q2 '26 estimate $1.12 Q2 '26 actual $1.14, beat Q3 '26 estimate $1.08 Q4 '26 estimate $1.21 Q1 '27 estimate $1.25 Q2 '27 estimate $1.33
Show 1 more >

Analyst Consensus ?

ConsensusHold41 ratings
Bullish1536.6%
Neutral2048.8%
Bearish614.6%

1 unmapped firm rating excluded from the percentages.

Analyst 52W Price Targets

$52.88Current
$41Low
$91.77Average
$135High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 2, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Wolfe Research Outperform Peer PerformUpgradeSep 15, 2026
TD Cowen Sell SellMaintainJul 29, 2026
Baird Outperform OutperformMaintainJul 29, 2026
Mizuho Outperform OutperformMaintainJul 21, 2026
Stifel Hold BuyDowngradeJul 16, 2026
Oppenheimer Outperform OutperformMaintainJul 16, 2026
Goldman Sachs Neutral NeutralMaintainJul 16, 2026
BNP Paribas Underperform UnderperformMaintainJul 16, 2026
Seaport Global Neutral BuyDowngradeJul 15, 2026
RBC Capital Sector Perform OutperformDowngradeJul 15, 2026
Citigroup Buy BuyMaintainApr 29, 2026
Barclays Equal Weight Equal WeightMaintainApr 29, 2026
B of A Securities Underperform UnderperformMaintainApr 20, 2026
JP Morgan Overweight OverweightMaintainJan 16, 2026
BNP Paribas Exane Underperform NeutralDowngradeJan 7, 2026
Jefferies Buy HoldUpgradeDec 10, 2025
UBS Buy BuyMaintainOct 22, 2025
Keybanc Sector Weight OverweightDowngradeJan 6, 2025
Deutsche Bank Buy BuyMaintainJul 24, 2024
Northcoast Research Neutral BuyDowngradeJul 19, 2024
Morgan Stanley Underweight UnderweightMaintainJul 12, 2023
Cowen & Co. Outperform OutperformMaintainFeb 24, 2023
Loop Capital Buy BuyMaintainFeb 1, 2023
Rosenblatt Buy BuyMaintainJul 28, 2021
Vertical Research Hold BuyDowngradeNov 17, 2020
Stifel Nicolaus Hold BuyDowngradeDec 17, 2019
BMO Capital Market Perform Market PerformMaintainApr 10, 2019
Susquehanna Neutral PositiveDowngradeNov 7, 2016
Bernstein Outperform Market PerformUpgradeApr 27, 2016
William Blair Market Perform OutperformDowngradeJul 22, 2015
Longbow Research Neutral BuyDowngradeApr 22, 2015
BB&T Capital Hold BuyDowngradeApr 13, 2015
Canaccord Genuity Hold HoldMaintainApr 9, 2015
Nomura Neutral NeutralMaintainFeb 4, 2015
Northland Securities Neutral BuyDowngradeDec 5, 2014
Northland Capital Markets Neutral BuyDowngradeDec 5, 2014
Buckingham Research Neutral NeutralMaintainOct 9, 2014
Bank of America Underperform NeutralDowngradeJul 31, 2014
Wedbush Neutral OutperformDowngradeApr 23, 2014
Pentair Buy BuyMaintainNov 28, 2012
MKM Partners Buy NeutralUpgradeNov 5, 2012
Credit Suisse Neutral NeutralMaintainOct 9, 2012
Show less

Named analyst price targets

Upside is calculated against the persisted current price $52.88. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Wolfe ResearchNigel Coe$91$56.18 +72.1%Sep 15, 2026
Robert W. BairdAnalyst unavailable$80$66.77 +51.3%Jul 29, 2026
Deutsche BankAndrew Krill$81$63.63 +53.2%Jul 27, 2026
Mizuho SecuritiesAnalyst unavailable$85$62.12 +60.7%Jul 21, 2026
BNP ParibasAnalyst unavailable$64$65.92 +21.0%Jul 16, 2026
OppenheimerAnalyst unavailable$94$64.57 +77.8%Jul 16, 2026
Stifel NicolausNathan Jones$65$64.33 +22.9%Jul 16, 2026
Goldman SachsAnalyst unavailable$72$64.33 +36.2%Jul 15, 2026
JefferiesAnalyst unavailable$90$64.33 +70.2%Jul 15, 2026
Robert W. BairdAnalyst unavailable$83$75.68 +57.0%Jul 15, 2026
RBC CapitalAnalyst unavailable$74$75.68 +39.9%Jul 15, 2026
OppenheimerAnalyst unavailable$115$81.94 +117.5%Apr 29, 2026
Stifel NicolausAnalyst unavailable$103$82.86 +94.8%Apr 29, 2026
Robert W. BairdAnalyst unavailable$110$82.86 +108.0%Apr 29, 2026
BarclaysAnalyst unavailable$92$82.86 +74.0%Apr 29, 2026
Stifel NicolausAnalyst unavailable$110$91.2 +108.0%Apr 14, 2026
BarclaysJulian Mitchell$102$97.28 +92.9%Feb 5, 2026
Seaport GlobalAnalyst unavailable$125$96.31 +136.4%Feb 4, 2026
OppenheimerBryan Blair$122$95.14 +130.7%Feb 4, 2026
RBC CapitalAnalyst unavailable$117$96.78 +121.3%Feb 4, 2026
Robert W. BairdAnalyst unavailable$117$94.79 +121.3%Feb 4, 2026
BNP ParibasAnalyst unavailable$90$100.03 +70.2%Jan 7, 2026
JefferiesSaree Boroditsky$135$101.86 +155.3%Dec 10, 2025
Wolfe ResearchNigel Coe$135$104.25 +155.3%Dec 9, 2025
BarclaysAnalyst unavailable$115$106.47 +117.5%Dec 4, 2025
OppenheimerAnalyst unavailable$128$103.45 +142.1%Nov 20, 2025
UBSDamian Karas$124$108.99 +134.5%Oct 22, 2025
RBC CapitalDeane Dray$124$109.02 +134.5%Oct 22, 2025
Robert W. BairdAnalyst unavailable$130$109.02 +145.8%Oct 22, 2025
BarclaysJulian Mitchell$127$109.02 +140.2%Oct 22, 2025
BarclaysAnalyst unavailable$125$110.61 +136.4%Oct 1, 2025
UBSDamian Karas$110$87.73 +108.0%Apr 23, 2025
Goldman SachsAnalyst unavailable$95$86.24 +79.7%Apr 22, 2025
Mizuho SecuritiesBrett Linzey$100$86.24 +89.1%Apr 22, 2025
Goldman SachsBrian Lee$103$98 +94.8%Oct 23, 2024
Seaport GlobalScott Graham$120$97.36 +126.9%Oct 23, 2024
KeyBancJeffrey Hammond$115$98.32 +117.5%Oct 23, 2024
RBC CapitalDeane Dray$115$98.32 +117.5%Oct 23, 2024
BarclaysJulian Mitchell$108$98.32 +104.2%Oct 23, 2024
Stifel NicolausNathan Jones$115$98.49 +117.5%Oct 16, 2024
KeyBancJeffrey Hammond$110$96.24 +108.0%Oct 11, 2024
BarclaysJulian Mitchell$105$96.81 +98.6%Oct 2, 2024
UBSDamian Karas$100$87.05 +89.1%Jul 24, 2024
KeyBancJeffrey Hammond$97$87.19 +83.4%Jul 24, 2024
BarclaysJulian Mitchell$96$87.19 +81.5%Jul 24, 2024
Stifel NicolausNathan Jones$100$81.76 +89.1%Jul 18, 2024
OppenheimerBryan Blair$92$80.05 +74.0%Jul 16, 2024
Robert W. BairdMichael Halloran$85$80 +60.7%Jun 25, 2024
RBC CapitalDeane Dray$99$80 +87.2%Jun 25, 2024
Stifel NicolausNathan Jones$94$79.2 +77.8%Apr 23, 2024
Northcoast ResearchRyan Connors$100$81.1 +89.1%Apr 15, 2024
RBC CapitalDeane Dray$101$82.8 +91.0%Apr 4, 2024
RBC CapitalDeane Dray$79$71.51 +49.4%Jan 11, 2024
KeyBancJeffrey Hammond$82$67.58 +55.1%Dec 13, 2023
Loop Capital MarketsAnalyst unavailable$75$56.6 +41.8%Feb 1, 2023
CitigroupAnalyst unavailable$65$56.44 +22.9%Feb 1, 2023
OppenheimerAnalyst unavailable$67$55.95 +26.7%Feb 1, 2023
BarclaysAnalyst unavailable$65$55.38 +22.9%Feb 1, 2023
BarclaysAnalyst unavailable$56$46.22 +5.9%Jan 5, 2023
Stifel NicolausStifel Stifel$57$43.66 +7.8%Dec 21, 2022
CitigroupAnalyst unavailable$54$45.07 +2.1%Dec 9, 2022
BarclaysAnalyst unavailable$48$41.25 -9.2%Oct 3, 2022
Stifel NicolausNathan Jones$47$48.89 -11.1%Jul 30, 2022
Morgan StanleyAnalyst unavailable$41$46.37 -22.5%Jul 15, 2022
Morgan StanleyAnalyst unavailable$49$49.58 -7.3%May 31, 2022
BarclaysAnalyst unavailable$50$48.37 -5.4%May 24, 2022
Cowen & Co.Analyst unavailable$75$53.38 +41.8%Apr 22, 2022
Morgan StanleyAnalyst unavailable$50$53.39 -5.4%Apr 22, 2022
BarclaysAnalyst unavailable$55$52.83 +4.0%Apr 22, 2022
RBC CapitalAnalyst unavailable$58$53.39 +9.7%Apr 22, 2022
UBSDamian Karas$74$76.2 +39.9%Sep 23, 2021
CitigroupAndrew Kaplowitz$86$70.87 +62.6%Jul 28, 2021
Boenning & ScattergoodRyan Connors$100$69.26 +89.1%Jul 13, 2021
Show less

Track every rating change on PNR the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Pentair plc engages in the provision of water solutions for residential, commercial, industrial, infrastructure, and agricultural applications. It operates through the following segments: Flow, Water Solutions, and Pool. The Flow segment designs, manufactures, and sells various fluid treatment and pump products and systems, including pressure vessels, gas recovery solutions, membrane bioreactors, wastewater reuse systems and advanced membrane filtration, separation systems, water disposal pumps, water supply pumps, fluid transfer pumps, turbine pumps, solid handling pumps, and agricultural spray nozzles, while serving the global residential, commercial, and industrial markets.…

Historical context

All PNR earnings

Industrials peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the PNR recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
  2. FN2 earnings calendar · 2026-07-26T00:36:15.940040+00:00
  3. Polygon adjusted daily market bars · 2026-10-01T23:56:06.817520+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-01T23:56:06.814710+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-10-01. For educational purposes only; not investment advice.